Ritu Baral
Stock Analyst at TD Cowen
(4.98)
# 63
Out of 4,587 analysts
1040
Total ratings
55.4%
Success rate
44.4%
Average return
Main Sectors:
Stocks Rated by Ritu Baral
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRD Opus Genetics | Initiated Coverage: Buy | n/a | $3.47 | - | 1 | Jul 29, 2026 | |
| PVLA Palvella Therapeutics | Reiterated: Buy | $267 | $142.60 | +87.24% | 16 | Jul 21, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintained: Buy | $482 | $286.62 | +68.17% | 100 | Jul 20, 2026 | |
| INSM Insmed | Maintained: Buy | $243 | $103.12 | +135.65% | 72 | Jul 20, 2026 | |
| MDGL Madrigal Pharmaceuticals | Maintained: Buy | $644 | $546.88 | +17.76% | 44 | Jul 20, 2026 | |
| ATAI AtaiBeckley | Downgraded: Hold | n/a | $7.18 | - | 21 | Jul 17, 2026 | |
| SION Sionna Therapeutics | Maintained: Buy | $49 | $44.81 | +10.27% | 9 | Jul 17, 2026 | |
| CMPS COMPASS Pathways | Maintained: Buy | $29 | $10.90 | +166.06% | 22 | Jul 13, 2026 | |
| KARD Kardigan | Initiated Coverage: Buy | $46 | $19.73 | +133.15% | 1 | Jul 13, 2026 | |
| VERA Vera Therapeutics | Maintained: Buy | $78 | $32.51 | +139.93% | 25 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $510 | $291.03 | +75.24% | 27 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 | $26.34 | +40.47% | 65 | Jun 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $306 → $403 | $363.28 | +10.93% | 40 | Jun 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $4.51 | +121.73% | 6 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €8.73 | €3.80 | +129.76% | 8 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $67 | $31.48 | +112.83% | 3 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $12.05 | - | 5 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $27.98 | - | 14 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $33.66 | - | 23 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.04 | +669.23% | 35 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $26.72 | - | 17 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.29 | - | 24 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $7.04 | +198.30% | 18 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 | $15.54 | +9.43% | 103 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $7.91 | +1.14% | 1 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.19 | - | 25 | Nov 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $15.96 | - | 15 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.0727 | - | 37 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.7351 | - | 11 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.02 | n/a | 5 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.05 | n/a | 12 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $41.45 | n/a | 2 | Nov 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $28.43 | n/a | 11 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $54.04 | n/a | 9 | Feb 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $14.77 | n/a | 22 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $49.06 | n/a | 5 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $74.49 | n/a | 37 | May 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $25.00 | n/a | 8 | Jan 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $40.07 | n/a | 17 | Dec 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0111 | n/a | 23 | Oct 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.00 | n/a | 4 | Jul 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $78.39 | n/a | 22 | Apr 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.61 | n/a | 14 | Apr 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $19.88 | n/a | 7 | Apr 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.65 | n/a | 7 | Mar 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.28 | n/a | 6 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 → $29 | $2.14 | n/a | 2 | May 15, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $291 → $355 | $209.23 | n/a | 5 | Jan 27, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $1.6 | $14.16 | n/a | 17 | Nov 18, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $3 | $0.0001 | n/a | 7 | Jul 9, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $6 | $2.27 | n/a | 5 | Jun 25, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.31 | n/a | 3 | Jun 18, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $13 | $11.67 | n/a | 1 | Mar 14, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $6.88 | n/a | 1 | Feb 21, 2012 |
Opus Genetics
Jul 29, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $3.47
Upside: -
Palvella Therapeutics
Jul 21, 2026
Reiterated: Buy
Price Target: $267
Current: $142.60
Upside: +87.24%
Alnylam Pharmaceuticals
Jul 20, 2026
Maintained: Buy
Price Target: $482
Current: $286.62
Upside: +68.17%
Insmed
Jul 20, 2026
Maintained: Buy
Price Target: $243
Current: $103.12
Upside: +135.65%
Madrigal Pharmaceuticals
Jul 20, 2026
Maintained: Buy
Price Target: $644
Current: $546.88
Upside: +17.76%
AtaiBeckley
Jul 17, 2026
Downgraded: Hold
Price Target: n/a
Current: $7.18
Upside: -
Sionna Therapeutics
Jul 17, 2026
Maintained: Buy
Price Target: $49
Current: $44.81
Upside: +10.27%
COMPASS Pathways
Jul 13, 2026
Maintained: Buy
Price Target: $29
Current: $10.90
Upside: +166.06%
Kardigan
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $19.73
Upside: +133.15%
Vera Therapeutics
Jul 7, 2026
Maintained: Buy
Price Target: $78
Current: $32.51
Upside: +139.93%
Jun 29, 2026
Maintained: Buy
Price Target: $510
Current: $291.03
Upside: +75.24%
Jun 26, 2026
Maintained: Buy
Price Target: $37
Current: $26.34
Upside: +40.47%
Jun 18, 2026
Maintained: Buy
Price Target: $306 → $403
Current: $363.28
Upside: +10.93%
Jun 9, 2026
Maintained: Buy
Price Target: $10
Current: $4.51
Upside: +121.73%
Jun 8, 2026
Maintained: Buy
Price Target: €8.73
Current: €3.80
Upside: +129.76%
May 14, 2026
Maintained: Buy
Price Target: $67
Current: $31.48
Upside: +112.83%
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $12.05
Upside: -
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $27.98
Upside: -
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $33.66
Upside: -
May 13, 2026
Maintained: Buy
Price Target: $8
Current: $1.04
Upside: +669.23%
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $26.72
Upside: -
May 12, 2026
Maintained: Buy
Price Target: n/a
Current: $2.29
Upside: -
May 12, 2026
Maintained: Buy
Price Target: $21
Current: $7.04
Upside: +198.30%
May 7, 2026
Maintained: Hold
Price Target: $17
Current: $15.54
Upside: +9.43%
Apr 13, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $7.91
Upside: +1.14%
Nov 16, 2025
Maintained: Hold
Price Target: n/a
Current: $1.19
Upside: -
Nov 10, 2025
Maintained: Buy
Price Target: n/a
Current: $15.96
Upside: -
Aug 11, 2025
Maintained: Buy
Price Target: n/a
Current: $0.0727
Upside: -
Aug 11, 2025
Maintained: Buy
Price Target: n/a
Current: $0.7351
Upside: -
Apr 11, 2025
Maintained: Hold
Price Target: n/a
Current: $5.02
Upside: n/a
Feb 18, 2025
Maintained: Buy
Price Target: n/a
Current: $1.05
Upside: n/a
Nov 23, 2021
Downgraded: Hold
Price Target: n/a
Current: $41.45
Upside: n/a
Mar 16, 2020
Maintained: Buy
Price Target: n/a
Current: $28.43
Upside: n/a
Feb 27, 2020
Maintained: Hold
Price Target: n/a
Current: $54.04
Upside: n/a
Feb 24, 2020
Maintained: Buy
Price Target: n/a
Current: $14.77
Upside: n/a
Aug 14, 2019
Rated: Buy
Price Target: n/a
Current: $49.06
Upside: n/a
May 8, 2019
Maintained: Hold
Price Target: n/a
Current: $74.49
Upside: n/a
Jan 6, 2019
Maintained: Buy
Price Target: n/a
Current: $25.00
Upside: n/a
Dec 3, 2018
Maintained: Buy
Price Target: n/a
Current: $40.07
Upside: n/a
Oct 12, 2018
Rated: Hold
Price Target: n/a
Current: $0.0111
Upside: n/a
Jul 2, 2018
Downgraded: Hold
Price Target: n/a
Current: $4.00
Upside: n/a
Apr 6, 2018
Maintained: Hold
Price Target: n/a
Current: $78.39
Upside: n/a
Apr 6, 2018
Maintained: Hold
Price Target: n/a
Current: $1.61
Upside: n/a
Apr 6, 2018
Maintained: Hold
Price Target: n/a
Current: $19.88
Upside: n/a
Mar 16, 2017
Reiterated: Buy
Price Target: n/a
Current: $4.65
Upside: n/a
Dec 30, 2016
Rated: Hold
Price Target: n/a
Current: $5.28
Upside: n/a
May 15, 2014
Rated: Buy
Price Target: $25 → $29
Current: $2.14
Upside: n/a
Jan 27, 2014
Reiterated: Buy
Price Target: $291 → $355
Current: $209.23
Upside: n/a
Nov 18, 2013
Initiated Coverage: Hold
Price Target: $1.6
Current: $14.16
Upside: n/a
Jul 9, 2012
Reiterated: Buy
Price Target: $6 → $3
Current: $0.0001
Upside: n/a
Jun 25, 2012
Reiterated: Hold
Price Target: $8 → $6
Current: $2.27
Upside: n/a
Jun 18, 2012
Reiterated: Buy
Price Target: $6
Current: $1.31
Upside: n/a
Mar 14, 2012
Upgraded: Buy
Price Target: $13
Current: $11.67
Upside: n/a
Feb 21, 2012
Reiterated: Buy
Price Target: $14
Current: $6.88
Upside: n/a